1. 1101Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction. (28th August 2018) Authors: Roy, C; Slimani, A; De Meester, C; Amzulescu, M; Ferracin, B; Ginion, A; Pasquet, A; Vancraeynest, D; Vanoverschelde, J.-L; Gerber, B; Beauloye, C; Horman, S; Gruson, D; Pouleur, A.-C Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1102Fibroblast growth factor 23 and extracellular volume as markers of myocardial fibrosis and poor outcome in heart failure with preserved ejection fraction. (28th August 2018) Authors: Roy, C; Slimani, A; De Meester, C; Amzulescu, M; Ferracin, B; Ginion, A; Pasquet, A; Vancraeynest, D; Vanoverschelde, J.-L; Gerber, B; Beauloye, C; Horman, S; Gruson, D; Pouleur, A.-C Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗